Marco Fiocchetti

9PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesPredictive and prognostic markersBiologically active moleculesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 17, 2024
Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167.

Emiliano Montalesi, Manuela Cipolletti, Patrizio Cracco

|Mar 29, 2023
A Novel Resveratrol-Induced Pathway Increases Neuron-Derived Cell Resilience against Oxidative Stress.

Patrizio Cracco, Emiliano Montalesi, Martina Parente

|Feb 11, 2023
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway.

Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia

|Dec 23, 2022
Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype.

Valentina Pallottini, Marco Segatto, Filippo Acconcia

|Nov 27, 2021
Neuroglobin in Retinal Neurodegeneration: A Potential Target in Therapeutic Approaches.

Virginia Solar Fernandez, Maria Marino, Marco Fiocchetti

|Oct 22, 2021
The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells.

Marco Fiocchetti, Giovanna Bastari, Manuela Cipolletti

Pageof 2

Frequent Collaborators

8 joint publications

Maria Marino

4 joint publications

Manuela Cipolletti

3 joint publications

Filippo Acconcia

2 joint publications

Marco Segatto